Daclizumab Subcutaneous and Hydrocodone and chlorpheniramine
Determining the interaction of Daclizumab Subcutaneous and Hydrocodone and chlorpheniramine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: chlorpheniramine / hydrocodone
Brand name: TussiCaps, Tussionex PennKinetic, S-T Forte 2, HyTan, Novasus, Vituz
Synonyms: Chlorpheniramine and hydrocodone, Hydrocodone and Chlorpheniramine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hydrocodone and Chlorpheniramine Extended-Release Capsules
- Daclizumab Subcutaneous-Hydrocodone and Chlorpheniramine Extended-Release Suspension
- Daclizumab Subcutaneous-Hydrocodone and Chlorpheniramine Oral Solution
- Daclizumab Subcutaneous-Hydrocodone and chlorpheniramine polistirex
- Daclizumab Subcutaneous-Hydrocodone and Chlorpheniramine Solution
- Daclizumab Subcutaneous-Hydrocodone and Guaifenesin
- Hydrocodone and chlorpheniramine-Dacogen
- Hydrocodone and chlorpheniramine-Dacomitinib
- Hydrocodone and chlorpheniramine-Dactinomycin
- Hydrocodone and chlorpheniramine-Dactinomycin Injection
- Hydrocodone and chlorpheniramine-Dactinomycin Intravenous
- Hydrocodone and chlorpheniramine-Daklinza